Many proteins can misfold into b-sheet-rich, self-seeding polymers (amyloids). Prions are exceptional among such aggregates in that they are also infectious. In fungi, prions are not pathogenic but rather act as epigenetic regulators of cell physiology, providing a powerful model for studying the mechanism of prion replication. We used prion-forming domains from two budding yeast proteins (Sup35p and New1p) to examine the requirements for prion formation and inheritance. In both proteins, a glutamine/asparagine-rich (Q/N-rich) tract mediates sequence-specific aggregation, while an adjacent motif, the oligopeptide repeat, is required for the replication and stable inheritance of these aggregates. Our findings help to explain why although Q/N-rich proteins are relatively common, few form heritable aggregates: prion inheritance requires both an aggregation sequence responsible for self-seeded growth and an element that permits chaperone-dependent replication of the aggregate. Using this knowledge, we have designed novel artificial prions by fusing the replication element of Sup35p to aggregation-prone sequences from other proteins, including pathogenically expanded polyglutamine.
Introduction
The aggregation of misfolded proteins underlies a diverse range of human diseases, including sporadic amyloidoses such as Alzheimer's disease and hereditary neuropathies such as Huntington's disease (Dobson 1999) . Prions are a special class of protein aggregates that replicate their conformation and spread infectiously (Prusiner 1998) . After the discovery that prion aggregates are responsible for the mammalian transmissible spongiform encephalopathies, several epigenetically heritable traits in fungi were also found to depend on a prion mechanism (Wickner 1994; Uptain and Lindquist 2002; Osherovich and Weissman 2004) . In Saccharomyces cerevisiae and Podospora anserina, prions are transmitted from cell to cell through mating and cell division, resulting in readily assayed phenotypes with a non-Mendelian pattern of inheritance .
The yeast non-Mendelian factors [PSI þ ] (Cox 1965) and [URE3] (Lacroute 1971) , which are prion forms of the translation termination factor Sup35p and the transcriptional activator Ure2p, respectively, have served as useful models for the formation and replication of heritable protein aggregates. Prion forms of Sup35p and Ure2p lead to defects in their respective biochemical activities (translation termination and nitrogen catabolite repression). Mutational analysis has shown the glutamine/asparagine-rich (Q/N-rich) amino-terminal (N) domains of these proteins to be critical for prion behavior (Ter-Avanesyan et al. 1993; Masison and Wickner 1995; Patino et al. 1996; Paushkin et al. 1996; DePace et al. 1998) . In vitro, these Q/N-rich domains form selfseeding, b-sheet-rich amyloid fibrils similar to those associated with Alzheimer's and Huntington's diseases (Glover et al. 1997; King et al. 1997; Taylor et al. 1999) . The autocatalytic aggregation of yeast prion proteins often shows a high specificity for like molecules; for example, Sup35p N domains from different yeast species form prion aggregates that preferentially interact with molecules of their own kind (Santoso et al. 2000; Chernoff et al. 2000; Kushnirov et al. 2000; Zadorskii et al. 2000; Nakayashiki et al. 2001) . [PSI þ ] and [URE3] can be eliminated by transient growth in the presence of guanidine hydrochloride (GuHCl), which ''cures'' cells of prions by inhibiting Hsp104p, a molecular chaperone needed for prion replication (Chernoff et al. 1995; Jung et al. 2002; Ness et al. 2002) .
A surprisingly large number of proteins in S. cerevisiae and other eukaryotes have lengthy Q/N-rich tracts ostensibly similar to those found in the prion-forming domains of Sup35p and Ure2p (Michelitsch and Weissman 2000) . From among these, we and another group identified two novel proteins, New1p and Rnq1p, with prion-forming domains resembling those of Sup35p and Ure2p (Santoso et al. 2000; Sondheimer and Lindquist 2000) . When these Q/N-rich domains were fused to green fluorescent protein (GFP) and overexpressed, they formed visible aggregates resembling those of GFP-labeled Sup35p in [ (Derkatch et al. 1997; Derkatch et al. 2001 (Krobitsch and Lindquist 2000; Osherovich and Weissman 2001; Meriin et al. 2002) . However, only a limited number of Q/N-rich sequences are bone fide prion domains capable of propagating these aggregates over multiple cell generations even when expressed at low levels (J. Hood and J.S.W, unpublished data). To understand what distinguishes generic Q/N-rich aggregates from heritable prions, we conducted a detailed dissection of the prionforming regions of Sup35p and New1p. We found that the prion properties of Sup35p and New1p require the presence of two independent and portable sequence elements within their prion domains. One element mediates the growth of prion aggregates by incorporation of soluble monomers. The second promotes the inheritance of aggregates, generating new heritable ''seeds'' which can be partitioned between mother and daughter cells during cell division. with diminished translation termination activity, which can be monitored by nonsense suppression of the mutant ade1-14 allele strains suppress the premature stop codon in ade1-14, and thus appear pink or white on YEPD medium and grow on adenine-free medium (a phenotype termed adenine prototrophy, Adeþ). The N or prion domain of Sup35p (residues 1-112) is required for [PSI þ ] formation but is dispensable for the translation termination activity of the carboxy-terminal C domain (Ter-Avanesyan et al. 1993) . The charged middle domain (M) is not required for prion behavior, but modulates the efficiency of chaperone-dependent prion transmission (Liu et al. 2002; L.Z.O., unpublished data) (Figure 1 ). Two distinct regions in the N domain have previously been implicated in Sup35p aggregation: a Q/N-rich tract (residues 1-39) (DePace et al. 1998 ) and an oligopeptide repeat (residues 40-112) that consists of five and a half degenerate repeats of the consensus sequence P/QQGGYQQ/SYN (Liu and Lindquist 1999; Parham et al. 2001; Crist et al. 2003) .
Results

Distinct Regions of the New1p Prion Domain Mediate Prion Growth and Division
We had earlier identified New1p as an uncharacterized protein with a Sup35p-like N-terminal domain; when fused to the M and C domains of Sup35p, the first 153 residues of New1p (New1 et al. 2000) . Sup35p and New1p have regions of clear similarity beyond their high Q/N content ( Figure 1 ). The prion domains of both have Q/N-rich tracts and oligopeptide repeat regions, although their order is reversed. The C-terminal domains of New1p and Sup35p also appear to be related, based on modest homology and the similarity of the translation termination defects in sup35 (Song and Liebman 1985) and new1 mutants (L.Z.O., unpublished data).
To understand the sequence requirements for the prion behavior of New1p, we constructed a series of truncated prion domains ( Figure 2A ) and examined their participation in several critical steps of the prion replication cycle. We first asked whether these truncated prion domains could form visible foci when fused to GFP (aggregation). Next, we examined whether such aggregates could convert New1 1-153 into a [NU þ ] prion state (induction). Finally, we fused these constructs to the M and C domains of Sup35p (-M-C), introduced them in place of endogenous SUP35, and assessed whether these proteins could adopt stable prion states (maintenance). We found that distinct regions within the New1p prion domain are necessary for the induction and maintenance of [NU þ ] (Figure 2A ). The asparagine-tyrosine-asparagine (NYN) repeat (residues 70-100), which we had earlier shown to be sufficient for aggregation (Osherovich and Weissman 2001) Figure 2B , left). However, stable prion maintenance required both the NYN repeat and the adjacent oligopeptide repeat. In a strain with this minimized New1p prion domain (residues 50-100), overexpression of the full prion domain or of the NYN repeat alone promoted the appearance of Adeþ colonies ( Figure 2B , right). The resulting convertants remained Adeþ after loss of the inducer plasmid but reverted to Ade-after transient GuHCl treatment ( Figure  2C ). We conclude that the oligopeptide repeat and the NYN repeat of New1p together are sufficient to support a prion state, termed [NU þ ] mini , which recapitulates the character- (Parham et al. 2001 ).
Dissection of the Sup35p Prion Domain
The PNM2-1 Mutation in Oligopeptide Repeat 2 Specifically Compromises the Inheritance of [PSI þ ]
Our deletion analysis suggested that oligopeptide repeat 2 participated in both the formation and inheritance of Sup35p aggregates. We made use of a point mutation within oligopeptide repeat 2 known as PNM2-1 (G58D) to distinguish between these two functions. PNM2-1 (PSI No More) shows strong interference with [PSI þ ] in certain strain backgrounds through a poorly understood mechanism (McCready et al. 1977; Doel et al. 1994; Kochneva-Pervukhova et al. 1998; Derkatch et al. 1999 . The symbol ''þ'' indicates induction frequencies of at least 5%; the symbol ''-'' indicates no induction. Maintenance was assessed by the ability of an episomal maintainer version of the indicated fragment to support an Adeþ state after overexpression of New1 1-153 -GFP (see Materials and Methods). The aggregation of New1-GFP fusions (second column) has been previously reported (Osherovich and Weissman 2001 recombinant PNM2-1 protein. Like wild-type Sup35p, purified PNM2-1 spontaneously formed amyloid fibrils in vitro; this was accelerated by the addition of preformed Sup35p polymer seeds (data not shown). We measured the initial rates of polymerization of wild-type and PNM2-1 protein seeded by preformed wild-type polymers ( Figure 4B ) and by PNM2-1 polymers ( Figure 4C ) using a thioflavin-T-binding assay. We observed that wild-type and PNM2-1 monomers were seeded by wild-type polymers with similar kinetics; likewise, PNM2-1 polymers seeded both wild-type and PNM2-1 monomers equivalently. Thus, the PNM2-1 mutation does not affect polymerization or seeding.
Instead, the PNM2-1 strain shows a marked defect in the inheritance of [ We next used a recently described assay to measure the number of heritable prion seeds (propagons) in a PNM2-1 strain. Here, prion replication is inhibited by GuHCl treatment. As the cells divide, preexisting propagons are diluted but not destroyed. The number of propagons present in a colony arising from a single cell is then evaluated by removing the GuHCl prion replication block after a large number (10 or more) of cell divisions and counting the total Figure 4F ). Thus, although a PNM2-1 strain can harbor [PSI þ ] prions, a defect in propagon replication causes mitotic instability, demonstrating the importance of oligopeptide repeat 2 in prion replication or segregation.
Design of Novel Prion Domains
Our data suggested that the formation and inheritance of prions involve distinct regions of Sup35p and New1p prion domains. To assess the interchangeability of these prion domain components, we constructed a chimeric prion domain, termed F, in which the aggregation-determining NYN repeat of New1p was fused to the oligopeptide repeats of Sup35p ( Figure 5A ). While initially soluble and active, a fusion of F and the Sup35p M and C domains (F-M-C) could be converted into an aggregated state, termed [
could be eliminated by GuHCl treatment ( Figure 5B ) and was inherited in a dominant, non-Mendelian manner ( Figure 5C ).
As with Sup35p in a [
extracts sedimented entirely to the pellet fraction following high-speed centrifugation ( Figure 5D ). Thus, [
results from a prion state of F-M-C. We next explored the specificity of [F þ ] prion seeding.
Overexpression of the Sup35p prion domain did not induce Figure 5E ). However, F-M-GFP readily induced New1p prion domains can cross-interact during de novo induction and at normal levels of expression, indicating that the NYN repeat is sufficient to specify homotypic interaction between two otherwise distinct prion domains. Can a simple aggregation-prone sequence such as polyglutamine (Zoghbi and Orr 2000) be turned into a heritable prion by fusion to an oligopeptide repeat? We designed artificial prion domains containing short (Q22) and pathogenically expanded (Q62) polyglutamine tracts, either alone or adjacent to the Sup35p oligopeptide repeat ( Figure 6A ). These domains were fused to -M-GFP and -M-C to create polyglutamine inducers and maintainers, respectively. Q22 inducers did not aggregate upon overexpression, but Q62 inducers (with and without oligopeptide repeats) formed Figure 6B ). Transient overexpression of Q62 inducers had no effect on the Q22 maintainer with the oligopeptide repeat or on the Q62 maintainer lacking the oligopeptide repeat. However, the Q62 maintainer with an oligopeptide repeat supported prion inheritance, converting to a stable Adeþ state following overexpression of the cognate inducer ( Figure 6C ). Several tests confirmed the prion nature of this state, 
Discussion
A number of epigenetic traits in fungi result from the stable inheritance of self-propagating, infectious protein aggregrates (prions) (Uptain and Lindquist 2002) . Prion inheritance requires three sequential events that must keep pace with cell division to preserve the number of heritable prion units, or propagons, per cell (Osherovich and Weissman 2004) . First, prion aggregates must grow in size by incorporating newly synthesized protein. Next, these enlarged aggregates must be divided into smaller ones through the action of cellular chaperones (Kushnirov and TerAvanesyan 1998; Borchsenius et al. 2001; Ness et al. 2002; Kryndushkin et al. 2003) . Finally, these regenerated propagons must be distributed to mother and daughter cells (Cox et al. 2003) ; for small, cytoplasmic aggregates, this distribution may occur passively by diffusion during cytokinesis. In the present study, we have dissected the prion-forming domains of Sup35p and New1p to discover the sequence elements involved in these steps. We have found that these domains consist largely of modular, interchangeable elements that serve distinct functions of prion growth and division or transmission.
Aggregation underlies the growth phase of the prion ] controls, were subjected to 50K 3 g ultracentrifugation for 15 min. Total, supernatant, and pellet fractions were separated by SDS-PAGE, transferred to nitrocellulose, and probed with anti-SUP35NM serum. As with Sup35p, the prion form of F-M-C sediments primarily to the pellet but remains in the
. Indicated inducers and maintainers were used in an induction experiment. The symbol '' þ '' indicates approximately 5-10% conversion to Adeþ. F induced [NU þ ] at a comparable efficiency to New1 1-153 ; although New1 1-153 overexpression promoted the appearance of Adeþ colonies in the F-M-C strain, these were fewer in number (less than 5%) and reverted to Ade-after restreaking. (F replication cycle ( Figure 7A ) and occurs through the templated addition of conformationally compatible monomers onto preexisting seeds. Like other amyloids, yeast prions display a high specificity for homotypic aggregation (Santoso et al. 2000; Chernoff et al. 2000; Kushnirov et al. 2000; Zadorskii et al. 2000; Nakayashiki et al. 2001 ). This discrimination arises from differences in the amino acid sequence and the conformation (Chien and Weissman 2001) of the aggregation-promoting Q/N-rich elements found in each yeast prion protein. Aggregation and specificity are dictated by the NYN repeat (residues 70-100) of New1p and by the Q/N-rich amino terminal region (residues 1-57) of Sup35p.
In contrast, the conserved oligopeptide repeat sequence mediates the division and/or segregation phase of prion replication ( Figure 7B) propagons. Oligopeptide repeats 1 and 2 appear to contribute to both growth and inheritance, consistent with earlier reports that expansion and deletion within this region modulate in vitro polymerization of Sup35p and the appearance of [PSI þ ] in vivo (Liu and Lindquist 1999) .
However, the two functions can be distinguished by a point mutant in oligopeptide repeat 2 (PNM2-1), which displays a specific defect in [PSI þ ] inheritance despite normal aggregation. Certain [PSI þ ] variants are resistant to the dominant negative effect of PNM2-1 King 2001) ; this suggests that although oligopeptide repeat 2 is critical for the replication of the [PSI þ ] variant used in our studies, it may be less important for the replication of other Sup35p prion conformations. Many studies have established that prion inheritance requires the action of cellular chaperones such as Hsp104p and Hsp70 proteins (reviewed in Osherovich and Weissman 2002) , although how these proteins contribute is poorly understood. We propose that oligopeptide repeats turn nonheritable aggregates into prions by facilitating chaperone-mediated division. Oligopeptide repeats may allow the division of aggregates by providing direct binding sites for chaperones or by altering the conformation of the amyloid core to allow chaperone access. An earlier study established that deletion of residues 22-69 of Sup35p (which include parts of both the Q/N tract and the oligopeptide repeat) interferes with both [PSI þ ] induction and chaperonemediated prion disaggregation (Borchsenius et al. 2001) . Unlike the D22-69 mutant, the prion replication defect in PNM2-1 could not be corrected by increasing Hsp104p levels (data not shown), arguing that the mitotic instability of PNM2-1 [PSI þ ] is not due solely to inadequate Hsp104p binding. Our findings help to explain why, among many Q/N-rich proteins in yeast, only a small subset form heritable prions. While many Q/N-rich proteins can aggregate when overexpressed (Sondheimer and Lindquist 2000; Derkatch et al. 2001; Osherovich and Weissman 2001) , prion inheritance of such aggregates requires that they be divided and passed on to the next generation. Although the inheritance of Sup35p and New1p prions is mediated by oligopeptide repeats, other sequences could also serve this purpose. Ure2p lacks an oligopeptide repeat; interestingly, many isolates of [URE3] are mitotically unstable in the absence of selection (Schlumpberger et al. 2001) . Rnq1p, which underlies [PIN þ ], also lacks a strict oligopeptide repeat, but a region (residues 218-405) within its prion domain has an amino acid content reminiscent of the oligopeptide repeat sequence (i.e., numerous Q, N, S, Y, and G residues) (Resende et al. 2003) .
Only two other yeast proteins, YDR210W and YBR016W, have clearly recognizable oligopeptide repeats; both proteins also have Q/N-rich regions. YBR016W forms aggregates when overexpressed (Sondheimer and Lindquist 2000) , but it is not known whether either protein can maintain a heritable aggregated state. Although the mammalian prion protein PrP contains a sequence resembling the oligopeptide repeat that can functionally replace one of the Sup35p repeats (Parham et al. 2001) , it is unclear whether this sequence is important in the replication of the PrP Sc state. The interchangeable nature of prion domain components allowed us to design novel artificial prions. The F chimera, consisting of the aggregation sequence of New1p and the oligopeptide repeat of Sup35p, demonstrates that the growth and specificity of prions is largely determined by the Q/N-rich tract, not by the oligopeptide repeat. Despite a sequence derived primarily from Sup35p, the F chimera behaved like New1p rather than like Sup35p. functions as an aggregation module apparently without regard to its position within a protein; this sequence induced prions when overexpressed by itself or with oligopeptide repeats at its N-terminal (in New1 1-153 and New1 50-100 ) or Cterminal regions (in the F chimera). These results suggest that aggregation sequences are portable and functionally separable from the oligopeptide repeat, perhaps constituting a structurally discrete amyloid core. Indeed, a peptide derived from the amino-terminal region of Sup35p forms a selfseeding amyloid in vitro (Balbirnie et al. 2001) . A simple aggregation-prone sequence, pathogenically expanded glutamine, also supports prion inheritance when adjacent to the oligopeptide repeat, suggesting that prion domains can consist of little more than a generic, aggregating core sequence and an inheritance-promoting element. In addition to illuminating the principles of yeast prion domain architecture, artificial prions with distinct specificity may be useful as controllable epigenetic regulators of protein activity. Such prion ''switches'' can be turned on and off by transient overexpression and genetic repression; for example, the Q prion domain could be fused to other proteins in order to conditionally and reversibly inactivate them independently of [PSI þ ]. It may also be possible to design additional artificial yeast prion domains whose aggregation is driven by non-Q/N-rich amyloidogenic proteins such as the Ab peptide that accumulates in Alzheimer's disease (Koo et al. 1999) or the mammalian prion protein PrP (Cohen and Prusiner 1998) . Such artificial prions could serve as models for aggregate-chaperone interactions in metazoans and could provide a genetic system for the high-throughput screening of modulators of human aggregation diseases.
Materials and Methods
Yeast strains and methods. Derivatives of W303 (Osherovich and Weissman 2001) , with the initial genotypes ade1-14, his3-11,15, leu2-3, trp1-1, and ura3-1, were used throughout unless otherwise noted; all strains were subsequently restreaked on SD-ade to select for [PSI þ ]. HIS3-marked oligopeptide repeat truncations and PNM2-1 maintainers were from Parham et al. (2001) ; all other Sup35p and New1p maintainers were marked with LEU2. The [f -] strain was generated by ''gamma'' chromosomal integration of pRS306 F-M-C into the SUP35 locus of YJW 584; excision of the wild-type gene was confirmed by PCR of Ade-colonies arising from subsequent growth on 5-FOA. The [q -] strain was made by ''omega'' chromosomal gene replacement (Kitada et al. 1995) (Sherman 1991) , but YEPD-medium plates contained 1/4 of the standard amount of yeast extract to accentuate color phenotypes. For prion curing, strains were grown on YEPD medium plus 3 mM GuHCl, then restreaked onto YEPD medium.
Plasmid and gene replacement construction. The modular SUP35 cloning system described in previous reports was used throughout (Santoso et al. 2000; Osherovich and Weissman 2001) . All plasmids are derived from Sikorski and Hieter (1989) ; sequence files of all constructs are available as a web supplement (Data S1). Maintainer plasmids are low-copy CEN/ARS (pRS31x series) with the native SUP35 promoter (Sp) driving the expression of the indicated prion domain followed by the M and C domains of Sup35p. Inducer plasmids are high-copy 2l (pRS42x series) with the inducible CUP1 promoter (Cp) driving the expression of the indicated prion domain followed by the Sup35p M domain and GFP. New1p inducers did not include the Sup35p M domain. For polyglutamine constructs, polyglutamine tracts (22 and 62) were amplified out of the MJDtr constructs used in an earlier study (Osherovich and Weissman 2001) . To permit amplification, primers contained sequences homologous to several codons adjacent to the 59 and 39 ends of the polyglutamine tracts plus an initiator ATG codon. Thus, the polyglutamine sequences read MAYFEK(Q22/62)DLSG. The resulting PCR fragments were cloned into maintainer and inducer plasmids, which were used as templates for gene replacement PCR (see yeast strains and methods, above).
In vivo prion assays. For aggregation, inducers were overexpressed by growth of cells in selective medium with 50 lM CuSO 4 until the culture reached stationary phase; cells were then examined by fluorescent microscopy (Zeiss Axiovert, Zeiss, Oberkochen, Germany; Metamorph imaging software, Universal Imaging Corporation, Downingtown, Pennsylvania, United States). Unless otherwise noted, cultures displaying 10% or more cells with foci were scored as positive. For induction, dilutions of the above cultures were plated onto SD-ade and YEPD media to determine percentage of Ade þ . In qualitative assessments, strains were scored as positive if 5% or more of plated cells grew on SD-ade medium after 5 d. ] strain was transformed with the indicated inducers, grown in selective medium with 50 lM CuSO 4 , and examined by fluorescence microscopy during midlogarithmic phase. Propagon counts were performed as described in Cox et al. (2003) . For the antisuppression assay, indicated strains were transformed with a second, differently marked maintainer plasmid, and color phenotypes were assayed on medium selective for both plasmids.
In vitro prion assays. Centrifugation was performed as described in Ness et al. (2002) . Immunoblots were visualized with MT130 antiSup35p N-M domain serum.For the polymerization of PNM2-1, the PNM2-1 N and M domains were cloned as 7-histidine fusions into pAED4 and expressed and purified as described in DePace et al. (1998) . Thioflavin-T binding was conducted as in Chien et al. (2003) . The slope of early (0-6 min) dye binding was obtained from seeded polymerization reactions conducted in triplicate. To correct for a difference in dye binding between wild-type and PNM2-1 protein, these values were normalized to the end point (90 min) maximum signal for each protein. Monomer concentrations were 2.5lM.
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Accession Numbers
The GenBank accession numbers for the proteins discussed in this paper are Hsp104p (NP_013074), New1p (NP_015098), Rnq1p (NP_09902), Sup35p (NP_010457), Ure2p (NC_014170), YDR210W (NP_010496), and YBR016W (NP_010319).
